XEN-D0501 is an experimental transient receptor potential vanilloid 1 (TRPV1) antagonist. It was acquired by Pila Pharma from Ario Pharma in 2016.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.